Skip to main content
. 2017 Jan 23;4(1):011009. doi: 10.1117/1.JMI.4.1.011009

Table 1.

Summary of patient demographics included in this study.

Patient no. Sex Age (years) Activity (MBq) Histology Stage Location Time postinjection (min)
1 M 50 312.1 Moderately differentiated squamous cell carcinoma T4N3 Right middle and lower lobe 60
2* M 30 234.8 Poorly differentiated nonsmall cell carcinoma not otherwise specified T3N2 Left upper lobe 60
3 F 34 315.9 Myoepithelial neoplasm with invasive carcinoma of squamous differentiation T4N0 Trachea and mediastinum and bilateral main bronchus 70
5 F 61 267.4 Nonsmall cell adenocarcinoma T2N2 Left upper lobe 55
6 F 62 261.2 Mucin secreting adenocarcinoma T3N2 Right lower lobe 55
7 M 45 281.8 Adenocarcinoma T4N2 Right lower lobe 60
8 M 65 268.2 Moderately differentiated squamous cell carcinoma T4N2 Right upper lobe 70
9** M 61 270.0 Moderately differentiated squamous cell carcinoma T3N3 Right upper lobe 65

Note: Patients 2* and 9** had two lesions and three lesions, respectively, with high PET uptake.